EPMA Journal - Meet our Editor-in-Chief
Olga Golubnitschaja, Dr. Professor
Prof. Dr. Golubnitschaja is the head of the world first Predictive, Preventive Personalised Medicine (3PM) unit at the Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany. OG is educated in biomedicine and has been awarded research fellowships in Austria, Russia, UK, Germany, Netherlands, and Switzerland (early and predictive diagnostics in paediatrics, neurosciences and cancer). Dr. Golubnitschaja is the author of more than 400 internationally peer-reviewed publications (research and review articles, position papers, books, book and congress contributions) in the innovative field of predictive, preventive and personalised medicine (3PM) with the main research focuses on sub-optimal health conditions, pre- and perinatal diagnostics, diagnostics of cardiovascular disease and neurodegenerative pathologies, predictive diagnostics in cancer and diabetes. Please, note! In years 1990-2002 published as Olga Labudova, Golubnitchaya-Labudova and Golubnitschaja-Labudova. Cumulative Scopus h-index is 61 – see 8403667700, 6701574933, 56628068200; 6506917890; Citations indexed by Google Scolar in 2023: >1200.
Awards: National & International Fellowship of the Alexander von Humboldt-Foundation; Highest Prize in Medicine and Eiselsberg-Prize in Austria; Springer-Nature Award; EMA Award.
In years 2009 – 2021 Dr. Golubnitschaja was the Secretary-General and since September 2021 she is the President of the “European Association for Predictive, Preventive & Personalised Medicine” (EPMA, Brussels) networking 56 countries worldwide, www.epmanet.eu. She is Editor-in-Chief of the EPMA J. (actual Scopus CiteScore 12.5) and Editor-in-Chief of the Book Series “Advances in Predictive, Preventive & Personalised Medicine” (Scopus indexed).
Dr. Golubnitschaja is the European Representative in the EDR-Network at the National Institutes of Health USA, http://edrn.nci.nih.gov/.
Dr. Golubnitschaja acts as a regular reviewer in over 50 clinical and scientific journals and as a grant reviewer of inter/national funding bodies in European and other countries.
Dr. Golubnitschaja is an evaluation expert at the European Commission. In years 2010-2013 she was involved in creating the PPPM related contents of the European Programme “Horizon 2020”.
Dr. Golubnitschaja as the Vice-Chair of the Habilitation Committee in years 2019-2023 was responsible for all medical specialisations at the Medical Faculty, University of Bonn, Germany.
Dr. Golubnitschaja acts as Vice-Chair of the Evaluation Panel for Marie Curie Mobility Actions at the European Commission in Brussels.
Dr. Golubnitschaja is a shareholder of the consulting company 3PMedicon, Austria specialised in 3PM.